Sunshine Charitable Foundation

The Sunshine Charitable Foundation is a deeply personal philanthropic vehicle established in 2016 by Geraldine Acuna-Sunshine and Gabriel B. Sunshine. The foundation's grantmaking is driven by a specific medical mission: advancing research and clinical care for movement disorders, particularly X-Linked Dystonia Parkinsonism (XDP), a rare neurodegenerative condition that affected Geraldine's brother. This personal connection shapes every aspect of the foundation's strategy. Rather than distributing grants broadly, the foundation concentrates virtually all of its $235 million in assets on supporting cutting-edge neuroscience research at Massachusetts General Hospital, where the Collaborative Center for XDP was co-founded by Geraldine. The foundation operates with zero employees and two unpaid trustees, channeling maximum resources directly into programmatic grants. A secondary but meaningful funding stream supports The Resolution Project, reflecting the founders' interest in youth social enterprise and leadership development.

The Sunshine Charitable Foundation exhibits a highly concentrated funding pattern that is unusual among foundations of its size. In fiscal year 2024, the foundation made a single grant of $10.05 million, following $9 million in FY2023 and $7.8 million in FY2022 -- all directed to Massachusetts General Hospital's neurology department for movement disorders research. This trajectory shows consistent year-over-year increases in the primary grant, suggesting deepening commitment as research progresses. The Resolution Project receives a smaller secondary allocation ($100,000-$634,000 annually), making it the only other consistent grantee. The foundation's total giving of approximately $10 million against $235 million in assets represents a payout rate of roughly 4.3%, approaching the 5% minimum required distribution. Revenue sources include contributions ($12.7M), investment income ($3.3M), and asset sale gains ($9.8M), indicating active portfolio management. The fiscal year runs July through June, and grants are typically awarded in a single annual cycle.

The Sunshine Charitable Foundation occupies a unique niche: it is far larger than disease-specific foundations like the Dystonia Medical Research Foundation but far more focused than broad medical research funders like Doris Duke. Its concentration on a single rare condition (XDP) with a single primary grantee (MGH) makes it more akin to a directed research fund than a traditional grantmaking foundation. Compared to the Michael J. Fox Foundation, which also funds movement disorder research but through open application processes, the Sunshine Foundation operates on a more targeted, relationship-driven model.

The foundation's FY2024 grant of $10.05 million to Massachusetts General Hospital marks its largest single award to date, continuing a pattern of annual increases. This funding supports the Collaborative Center for X-Linked Dystonia Parkinsonism (CCXDP) at MGH, which Geraldine Acuna-Sunshine co-founded to coordinate international research efforts on XDP. The CCXDP facilitates cross-institutional collaborations among scientists at Harvard, Yale, MIT, and institutions worldwide. Geraldine serves on multiple boards including the ADL, Harvard Board of Overseers (first Filipino-American elected), and Harvard Hillel, extending the foundation's influence through personal networks. The foundation's website at sunshinecharitablefoundation.org remains in pre-launch status with a 'Launching Soon' placeholder, suggesting the foundation may be preparing for broader public engagement. Gabriel Sunshine, co-founder of the hedge fund Bracebridge Capital (est. 1994), continues to serve as co-trustee, and contributions to the foundation increased 75.9% in FY2024 to $12.7 million.

Prospective applicants should understand that the Sunshine Charitable Foundation operates with an extremely narrow focus and concentrated grantee pool. To be competitive, organizations should: (1) Demonstrate direct relevance to movement disorder research, particularly X-Linked Dystonia Parkinsonism (XDP) or closely related neurodegenerative conditions -- this is the foundation's primary mission and receives over 95% of all grant funding; (2) Build connections through the CCXDP network at Massachusetts General Hospital, as the foundation's grantmaking is deeply integrated with this research center; (3) For organizations outside neurology, consider alignment with the youth social enterprise space, as The Resolution Project is the only non-medical grantee; (4) Use the website contact form at sunshinecharitablefoundation.org to express interest, as the foundation reports funding approximately 12% of new applications; (5) Emphasize international collaboration capacity, particularly with Philippine research institutions, given the founders' personal connection to XDP communities in the Philippines; (6) Be prepared for a long cultivation period, as the foundation's small grantee pool and personal mission suggest relationship-based rather than application-based decision-making.